IBBL LCS

Pathology : Oncology / Cancer

Study Title

Biomarker Discovery and Validation in Lung Cancer

Study Detail

Study Objective

The primary objective of this study is to discover and validate molecular biomarkers for lung cancer.

Participation conditions

INCLUSION CRITERIA

Patients with a suspected or confirmed diagnosis of lung cancer

Patients scheduled for:

Blood + urine sampling and
Lesion biopsy or / and
Surgical resection and, if applicable
Thoracentesis

EXCLUSION CRITERIA

Pregnant women
Minors (subjects less than 18 years of age)
Prisoners
Subjects unable to consent for themselves

Centers

Luxembourg : CHL, Zithaklinik, CHEM, CHdN

Belgium : Cliniques Universitaires St-Luc, UCL, Bruxelles

Contact person

Roxane Batutu
roxane.batutu@crp-sante.lu
+352 26 970- 809

Tags: oncology, cancer, lung, biomarker, tumor, IBBL, LCS

Search

for articles/videos/studies

All therapeutic areas

Studies overview

This page provides the list of clinical studies currently registered in the LuxCLIN platform in the different therapeutic areas. By clicking on each study title, more information is displayed concerning the study objective and the participation conditions.